Clinically Significant Monocyte Biomarker for Differential Diagnosis of COVID-19 Pneumonia in the Emergency Department / 계명의대학술지
Keimyung Medical Journal
; : 26-31, 2021.
Article
em En
| WPRIM
| ID: wpr-901494
Biblioteca responsável:
WPRO
ABSTRACT
Objectives@#To determine basic patient characteristics and biomarkers to help in the early diagnosis of Coronavirus disease 2019 (COVID-19) pneumonia in patients with pneumonia who visited the emergency department (ED). @*Methods@#This retrospective study evaluated patients diagnosed with community-acquired pneumonia (CAP) or COVID-19 pneumonia in ED at four tertiary medical centers between February 1 and March 31, 2020. Parameters related to the differential diagnosis between CAP and COVID-19 were investigated. Clinical characteristics and laboratory results of biomarkers were analyzed. @*Results@#In total, 81 patients presented to the ED with COVID-19 pneumonia. Multivariate logistic regression analysis showed that monocyte count [odds ratio (OR) 0.996; 95% confidence interval (CI) 0.994–0.999] and pneumonia severity index (PSI) [OR 1.025; 95% CI 1.002–1.049] were associated with diagnosis of COVID-19 pneumonia. The area under the curve comprising the combination of monocyte and PSI was 0.789. @*Conclusion@#Differential diagnosis of COVID-19 pneumonia from pneumonia patients who visited the emergency room can be made by monocyte count and PSI score.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Screening_studies
Idioma:
En
Revista:
Keimyung Medical Journal
Ano de publicação:
2021
Tipo de documento:
Article